Breast Cancer Now study to explore personalised drug doses
December 9, 2025Research and Development Breast Cancer Now, Oncology
Breast Cancer Now has announced a new study to evaluate whether personalised drug doses could improve quality of life for …
insitro appoints Stephen Hitchcock and Vijay Pande as scientific advisors
December 9, 2025insitro, scientific advisor
insitro, an AI therapeutics company, has announced the appointment of Stephen Hitchcock and Vijay Pande as scientific advisors. Hitchcock brings …
STADA appoints Ole Wendler Pedersen as Executive VP Legal and General Counsel
December 8, 2025Executive VP Legal and General Counsel, Stada
German pharmaceutical company STADA has announced the appointment of Ole Wendler Pedersen as its new Executive Vice President Legal and …
UCB presents positive results for fenfluramine in CDKL5 deficiency disorder
December 8, 2025Research and Development Neurology, UCB, epilepsy
UCB has announced positive results from its phase 3 GEMZ study, showing that fenfluramine can significantly reduce the frequency of …
Teva announces positive results from trial of AJOVY for migraine
December 5, 2025Research and Development Neurology, Teva, migraine
Teva has announced positive results from the phase 4 PEARL study of AJOVY (fremanezumab), its treatment for chronic (CM) and …
Vetter announces leadership transition as Thomas Otto retires
December 5, 2025Managing Director, Vetter
Vetter has announced the retirement of managing director Thomas Otto amid strategic plans for restructuring its management team. Otto has …
Samsung Bioepis announces launch of two new denosumab biosimilars in Europe
December 4, 2025Sales and Marketing Oncology, Osteoporosis, Samsung Bioepis
Samsung Bioepis has announced the European launch of Obodence and Xbryk, two new denosumab biosimilars approved for the treatment of …
Medicus Pharma appoints Carolyn Bonner as CFO
December 4, 2025Medicus Pharma, chief financial officer
Medicus Pharma has announced the appointment of Carolyn Bonner as Chief Financial Officer (CFO) in addition to her role as …
Sandoz launches two new bone disease biosimilars in Europe
December 3, 2025Sales and Marketing Oncology, Osteoporosis, Sandoz
Sandoz has announced the European launch of two new bone disease biosimilars. Wyost (denosumab 120 mg) is approved for the …
Faron Pharmaceuticals appoints Jurriaan Dekkers as Chief Financial Officer
December 3, 2025Faron Pharmaceuticals, chief financial officer
Faron Pharmaceuticals, a clinical-stage biopharmaceutical company, has appointed Jurriaan Dekkers as its new Chief Financial Officer (CFO). Dekkers most recently …
Medicus Pharma shares updates on basal cell carcinoma trials
December 2, 2025Research and Development Medicus Pharma, Oncology
Medicus Pharma has announced updates on the progress of SKNJCT-003 and SKNJCT-004, its clinical trials studying the efficacy of a …
Arnold & Porter appoints George Jenkins as partner
December 2, 2025Arnold & Porter, law, life sciences
Arnold & Porter has announced the appointment of George Jenkins as a partner in the firm’s Corporate & Finance practice. …
Safeguarding health and well-being for employees – the value of occupational health services
December 1, 2025Medical Communications Chartered Institute of Personnel and Development, Society of Occupational Medicine, employee health and well-being, occupational health, workplace sickness absence levels
With workplace sickness absence levels stuck at record levels, employers need to step-change how they think about and manage employee …
Men’s health – a new report from the Department of Health and Social Care
November 28, 2025Medical Communications Men's Health Strategy, Men's mental health, UK Department of Health and Social Care, medical communications, medical education, mental health
The UK Department of Health and Social Care has published a new report entitled Men’s health: a strategic vision for …
Healing the fracture in the system: the case for universal fraction liaison services access
November 28, 2025Medical Communications, Research and Development Osteoporosis
By Tina Backhouse In 2024, the UK government committed to achieving 100% coverage of Fracture Liaison Services (FLS)across the NHS …
Five Facts about antimicrobial resistance
November 28, 2025Medical Communications Antimicrobial resistance (AMR), Five Facts
1 Antimicrobial resistance (AMR) is when bacteria, viruses, fungi and parasites no longer respond to antimicrobial agents such as antibiotics.1 Around 35,000 …
Celltrion’s Remsima IV approved by EC in liquid form
November 27, 2025Research and Development Celltrion Inc, Immunology
Celltrion’s Remsima IV, the first-ever liquid formulation of infliximab for autoimmune diseases, has been approved by the European Commission (EC). …
One-carbon Therapeutics starts new cancer therapy trial
November 27, 2025Research and Development Oncology, One-carbon Therapeutics
Clinical-stage biotechnology company One-carbon Therapeutics has announced that the first subject has been dosed in its clinical trial for TH9619, …
Major breakthrough in T-cell receptor therapy manufacturing
November 27, 2025Manufacturing and Production Terumo BCT, cell therapy
For the first time, researchers at the University of Chicago in the US have successfully completed all three critical steps …
Gilead announces first shipments of HIV prevention drug to Eswatini and Zambia
November 27, 2025Product launch Gilead, HIV/AIDS
Gilead has announced the first shipments of its HIV prevention drug lenacapavir to Eswatini and Zambia, a milestone in the …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
